Tuesday, June 16, 4:00 – 5:30 pm
Auditorium Lulli

Chairs: Manfred Lutz (German) – Anneli Elme (Estonia) – Mike Gibson (USA)

1. ESMO standards of care: equal to other countries in the world? – Jonas Feilchenfeldt (Switzerland) 
2. Eastern Perspectives on Esophageal Cancer – Exploring Regional Differences in Clinical Characteristics and Treatment Strategies, with a Focus on ESD. – Hwoon-Yong Jung (Korea)
3. Molecular response prediction in esophageal squamous cell carcinomas: results of the EORTC/SAKK POWER project. – Alexander Siebenhuener (Switzerland)
4. IO tailored personalized medicine included side effects, drug holidays and maintenance. – Markus Moehler (Germany)
5. Oligometastatic disease: recommendations or studies ahead? – Şuayib Yalçın (Turkey)
6. Surveillance after “cure”? – Anneli Elme (Estonia) 
7. Overview of the ECOG-ACRIN Microbiome Working Group Clinical Trials – Mike Gibson (USA)
8. Biomarker in advanced esophageal cancers: what do we need to know. – Rupert Langer (Austria) 
9. Oral Abstract Presentation: Macrophage Infiltration and FoxP3 Density Predict Treatment Response and Survival in Esophageal Cancer Patients. – Styliani Mantziari (Switzerland)
10. Oral Abstract Presentation: Prognostic Impact of Treatment Modalities and Examined Lymph Nodes Count on Survival in T3–4 Esophageal Cancer: A Retrospective Cohort and Predictive Modeling Study from the SEER Database. – BenBen Zhu (China)